Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PFE

Pfizer Inc

Dec 24 • 04:00PM ET

26.74

Dollar change +0.03
Percentage change 0.11	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK JNJ ABBV BMY LLY GILD AMGN BIIB REGN VRTX

| Held by: VTI VOO SCHD SPY IVV VTV XLV VYM VHT IWD

Scroll to Statements

Index	S&P 500	P/E	35.95	EPS (ttm)	0.74	Insider Own	0.03%	Shs Outstand	5.67B	Perf Week	0.95%
Market Cap	151.54B	Forward P/E	9.24	EPS next Y	2.90	Insider Trans	-0.24%	Shs Float	5.67B	Perf Month	4.02%
Income	4.27B	PEG	4.76	EPS next Q	0.47	Inst Own	67.55%	Short Float	1.51%	Perf Quarter	-7.78%
Sales	60.11B	P/S	2.52	EPS this Y	58.79%	Inst Trans	0.25%	Short Ratio	2.02	Perf Half Y	-2.70%
Book/sh	16.29	P/B	1.64	EPS next Y	-0.92%	ROA	1.97%	Short Interest	85.37M	Perf Year	-6.06%
Cash/sh	1.76	P/C	15.23	EPS next 5Y	7.55%	ROE	4.52%	52W Range	24.48 - 31.54	Perf YTD	-7.33%
Dividend Est.	1.67 (6.23%)	P/FCF	18.42	EPS past 5Y	-27.43%	ROI	2.84%	52W High	-15.22%	Beta	0.62
Dividend TTM	1.68 (6.28%)	Quick Ratio	0.73	Sales past 5Y	10.96%	Gross Margin	58.50%	52W Low	9.23%	ATR (14)	0.59
Dividend Ex-Date	Jan 24, 2025	Current Ratio	1.00	EPS Y/Y TTM	-59.54%	Oper. Margin	16.32%	RSI (14)	55.73	Volatility	2.25% 2.06%
Employees	88000	Debt/Eq	0.73	Sales Y/Y TTM	-12.29%	Profit Margin	7.11%	Recom	2.23	Target Price	31.50
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	284.91%	Payout	439.41%	Rel Volume	0.47	Prev Close	26.71
Sales Surprise	18.63%	EPS Surprise	72.53%	Sales Q/Q	33.78%	Earnings	Oct 29 BMO	Avg Volume	42.31M	Price	26.74
SMA20	3.48%	SMA50	-0.18%	SMA200	-4.37%	Trades		Volume	19,716,308	Change	0.11%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Dec-25-24 10:15AM	4 Dividend Stocks to Double Up on Right Now (Motley Fool)
09:17AM	Is Pfizer Inc. (PFE) the Best Dividend Stock to Buy Under $50? (Insider Monkey)
08:45AM	Better Income Stock: Pfizer or Altria Group? (Motley Fool)
06:30AM	Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst (Yahoo Finance Video)
Dec-24-24 09:00PM	The Big Companies Funding Trumps Inauguration Despite Denouncing Jan. 6 (The Wall Street Journal)
12:20PM	Loading…
12:20PM	3 biggest catalysts expected for healthcare in 2025 (Yahoo Finance Video)
Dec-23-24 09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:20AM	Pfizers colorectal cancer combo therapy gains accelerated approval from FDA (Pharmaceutical Technology)
05:50AM	Stocking Stuffers for Income Investors: 3 Ultra-High-Yield Dividend Stocks to Buy Before the End of 2024 (Motley Fool)
Dec-22-24 04:25PM	Stuart Therapeutics Announces the Appointment of Two New Board Members (PR Newswire)
11:13AM	Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years? (Insider Monkey)
07:00AM	Pfizer Just Reassured Investors, but Is the Stock a Buy? (Motley Fool)
06:50AM	2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off (Motley Fool)
Dec-21-24 09:41AM	Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts (Insider Monkey)
05:06AM	Loading…
05:06AM	The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025 (Motley Fool)
04:05AM	My Top 10 Stocks to Buy for 2025 (Motley Fool)
Dec-20-24 07:44PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
02:48PM	Novo Nordisk Shares Plunge After New Obesity Shot Disappoints (The Wall Street Journal)
02:03PM	U.S. FDA Approves Pfizers BRAFTOVI Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer (Business Wire)
10:31AM	Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? (Investor's Business Daily)
07:19AM	Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now? (Insider Monkey)
Dec-19-24 05:45PM	Why Pfizer (PFE) Dipped More Than Broader Market Today (Zacks)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts (Business Wire)
08:00AM	Is Pfizer Stock A Buy After Rallying On Its 2025 Guidance? (Investor's Business Daily)
06:07AM	Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26? (Motley Fool)
06:00AM	Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature (Business Wire)
03:00AM	Mercks RSV antibody could soon paddle into the rough waters of a crowded market (Pharma Voice)
Dec-18-24 02:55PM	Jim Cramers Take on Pfizer (PFE): Can CEO Dr. Bourlas Bold Strategy Overcome Debt and Turn the Stock Around? (Insider Monkey)
08:45AM	Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic and Anal Cancers (GlobeNewswire)
08:00AM	Loading…
08:00AM	Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy (Investor's Business Daily)
07:08AM	Fed decision looms, Nvidia looks to rebound: Yahoo Finance (Yahoo Finance Video)
06:44AM	The Dows Losing Streak Isnt a Huge Worry for Markets, Why the Fed Is. And 5 Other Things to Know Today. (Barrons.com)
04:51AM	3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025 (Motley Fool)
02:39AM	Big Pharmas new DTC play: partnering with digital health providers (Pharma Voice)
Dec-17-24 05:34PM	Pfizer climbs 4% on 2025 outlook (CNBC TV)
05:10PM	S&P 500 Gains and Losses Today: Health Care Stocks Fall as Trump Eyes 'Middlemen' (Investopedia)
04:06PM	Pfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook (Investor's Business Daily)
03:42PM	Analyst Report: Pfizer Inc. (Morningstar Research)
01:51PM	Top Stock Movers Now: Amentum Holdings, Humana, Nvidia, and More (Investopedia)
12:28PM	Pfizer's 2025 Outlook: Is This the Breakthrough Investors Have Been Waiting For? (GuruFocus.com)
11:03AM	Pfizer Shares Jump 4% on Positive 2025 Outlook Despite $1B Impact (GuruFocus.com)
10:44AM	Pfizer Stock Rises as 2025 Outlook in Line With Expectations (Investopedia)
10:41AM	Pfizers In-Line Guidance Offers Relief to Weary Investors (Bloomberg)
10:09AM	Pfizer issues 2025 outlook in-line with Wall Street, shares rise (Yahoo Finance Video)
09:08AM	Pfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion (GuruFocus.com)
08:07AM	Pfizer Sees 2025 Revenue in Line With Wall Street Views (The Wall Street Journal)
07:20AM	Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion (Barrons.com)
07:15AM	Is Pfizer Inc. (PFE) the Best Weight Loss Stock to Buy Now According to Hedge Funds? (Insider Monkey)
06:56AM	Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround (Reuters)
06:45AM	Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance (Business Wire)
06:07AM	Prediction: 2 Stocks That'll Be Worth More Than Palantir 5 Years From Now (Motley Fool)
Dec-16-24 01:53PM	What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? (Benzinga)
04:15AM	Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 (Motley Fool)
Dec-15-24 07:53AM	Is Pfizer a Millionaire Maker? (Motley Fool)
Dec-14-24 08:16AM	Pfizer (PFE) Is Too Cheap To Ignore (Insider Monkey)
Dec-13-24 12:20PM	Pfizer Raises Quarterly Dividend to $0.43, Offering 6.66% Yield (GuruFocus.com)
12:15PM	Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report (Benzinga)
09:59AM	Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell In December 2024? (Investor's Business Daily)
08:20AM	Pfizer announces results from PATINA trial (TipRanks)
07:55AM	SABCS: Pfizers IBRANCE combo improves PFS in breast cancer study (Clinical Trials Arena)
02:51AM	Will the anti-woke movement derail DEI efforts in pharma? (Pharma Voice)
Dec-12-24 05:25PM	Pfizer Declares First-Quarter 2025 Dividend (Business Wire)
12:35PM	Pfizer's Cancer Drug Ibrance Combo Therapy Extends Median Progression-Free Survival By Over 15 Months In certain Of Breast Cancer Patients (Benzinga)
10:58AM	Pfizer and Amazon Explore Collaboration with RFK Jr. on Climate and Health Crisis (GuruFocus.com)
08:15AM	Pfizers IBRANCE in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer (Business Wire)
03:00AM	How Pfizer management outplayed activist investor Starboard (Pharmaceutical Technology)
Dec-11-24 05:45PM	Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
12:23PM	Health execs reckon with patient outrage after UnitedHealthcare killing (Reuters)
12:23PM	Health care execs seek to better understand patient outrage after UnitedHealthcare killing (Reuters)
05:38AM	Arvinas and Pfizers combo therapy shows promise in breast cancer trial (Clinical Trials Arena)
Dec-10-24 11:39PM	Is Pfizer Inc. (PFE) the Best American Dividend Stock to Buy Right Now? (Insider Monkey)
01:23PM	Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients (Benzinga)
10:33AM	RSV prophylactic market to reach $6.2bn in 8MM by 2030 (Pharmaceutical Technology)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of December 17 Conference Call with Analysts to Provide Full-Year 2025 Financial Guidance (Business Wire)
09:05AM	Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium (GlobeNewswire)
07:22AM	ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T (BioPharma Dive)
05:48AM	3 Magnificent S&P 500 Dividend Stock Down 35% to Buy and Hold Forever (Motley Fool)
Dec-09-24 09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-08-24 09:14PM	Apple Tops the List of Best-Managed Companies of 2024 (The Wall Street Journal)
09:00AM	Should You Buy the S&P 500's Highest-Yielding Dividend Stocks Heading Into 2025? (Motley Fool)
Dec-07-24 11:27AM	Want an Extra $1,000 of Dividend Income in 2025? Invest $11,400 in These 3 High-Yield Stocks. (Motley Fool)
05:30AM	Dividend Stocks Are Primed for a Comeback in 2025 (The Wall Street Journal)
Dec-06-24 03:22AM	Why Pfizer (PFE) Is Among the Best Affordable Stocks to Buy Right Now (Insider Monkey)
Dec-05-24 05:06PM	Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS (Business Wire)
07:15AM	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (Motley Fool)
04:55AM	Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now. (Motley Fool)
Dec-04-24 01:12PM	Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS? (Investor's Business Daily)
Dec-03-24 01:52PM	Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments (Benzinga)
Dec-02-24 07:48AM	Analyst Report: Pfizer Inc. (Morningstar Research)
06:46AM	Hong Kong regulator accepts Everest's ulcerative colitis therapy NDA (Pharmaceutical Business Review)
04:33AM	3 Magnificent Dividend Stocks With Yields Above 6% to Buy in December (Motley Fool)
Dec-01-24 05:52AM	3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later (Motley Fool)
Nov-29-24 09:00AM	How Much Would It Take To Earn $100 A Month From Pfizer Stock? (Benzinga)
08:45AM	Is This a New Reason to Buy Pfizer Stock Hand Over Fist? (Motley Fool)
04:53AM	Black Friday Sale for Income Investors: These 3 Ultra-High-Yield Dividend Stocks Are Bargain Buys (Motley Fool)
Nov-28-24 11:31AM	Pfizer (PFE) Down 9.4% Since Last Earnings Report: Can It Rebound? (Zacks)
09:40AM	Are Investors Undervaluing Pfizer (PFE) Right Now? (Zacks)
06:17AM	Is Pfizer Stock in Trouble? (Motley Fool)
05:39AM	Why Pfizer Inc. (PFE) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience